Loading market intelligence…
Cellular Atlas is a fictional biotechnology company used to demonstrate SVI's private-market intelligence tools. All financing, valuation and investor relationships on this profile are illustrative.
Cellular Atlas is a fictional biotechnology company used to demonstrate SVI's private-market intelligence tools. All financing, valuation and investor relationships on this profile are illustrative.
Position by illustrative valuation within the tracked sector.
Explore sector ↗| 2026-08-15 | Series C+ | $147M | $16.3B | Redwood Partners | Northstar Ventures, Bayview Ventures | Demo · Unverified |
| 2025-03-12 | Series A | $47M | Not disclosed | Redwood Partners | Northstar Ventures, Bayview Ventures | Demo · Unverified |
| 2024-09-08 | Seed | $10M | Not disclosed | Redwood Partners | Northstar Ventures, Bayview Ventures | Demo · Unverified |
Illustrative founding year
| Helix Discovery | Biotech | $36.1B | $483M | Growth |
| Cedar Bio | Biotech | $10.5B | $129M | Series C+ |
| Oak Bio | Biotech | $7.8B | $95M | Series B |
| Juniper Bio | Biotech | $6.2B | $75M | Series B |
All metrics on this profile originate in the SVI illustrative dataset. Published and retrieved Sep 18, 2026. Last verified: not verified. No original external publication exists for synthetic records.
Demo dataset · Sep 18, 2026